State Food and Drug Administration (China)
Subscribe to State Food and Drug Administration (China)

The Lead

Asia Agencies Purchase U.S. Simulation Software

April 6, 2015 12:01 pm | by Simulations Plus | News | Comments

Simulations Plus announced that several regulatory agencies around the world have added licenses of software for pharmaceutical discovery and development within the past three months.

China Says Vaccines Didn't Cause 9 Kids' Deaths

January 3, 2014 8:18 am | by GILLIAN WONG, Associated Press | News | Comments

Vaccines did not cause the deaths of nine children shortly after they were inoculated for...

China Launches Crackdown on Drug Industry

July 17, 2013 8:23 am | by JOE McDONALD,AP Business Writer | News | Comments

China announced a crackdown today on misconduct in...

Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines

May 24, 2013 8:26 am | News | Comments

Sinovac Biotech Ltd. a provider of biopharmaceutical products in China, announced that Sinovac...

View Sample

FREE Email Newsletter

Eddingpharm Signs Collaboration Agreement with GlaxoSmithKline China for Novel Breast Cancer Drug

April 9, 2013 8:13 am | News | Comments

Eddingpharm a specialty pharmaceutical company based in China, has announced that the company has entered into a collaboration agreement with GSK, whereby Eddingpharm will acquire from GSK the exclusive right in mainland China to import, market, promote, distribute and sell Tykerb, a treatment for advanced or metastatic breast cancer that was recently approved by the SFDA.

China Sentences 7 to Prison for Toxic Gel Capsules

February 7, 2013 8:15 am | News | Comments

Chinese state media say a court has sentenced seven people to prison for producing chromium-tainted gel medicine capsules. The scandal that was exposed in April 2012 was the latest to rock China's pharmaceutical industry, which suffers from abundant fakery and substandard ingredients.

American Oriental Bioengineering Undergoing SFDA Directed Inspection of Capsules

April 20, 2012 4:02 am | News | Comments

American Oriental Bioengineering, Inc., today announced that four out of its five manufacturing subsidiaries are undergoing onsite short notice inspections directed by China State Food and Drug Administration ("SFDA").  


China Suspends Sale of Drugs in Unsafe Capsules

April 16, 2012 4:17 am | News | Comments

BEIJING (AP) — China's State Food and Drug Administration has suspended the sale of 13 drugs that it says are believed to have been made with capsules that contain excessive chromium.  

Novartis Receives Chinese OK for Eye Drug Lucentis

January 18, 2012 3:10 am | by The Associated Press | News | Comments

Novartis said today that it received Chinese regulatory approval for its eye drug Lucentis, and it is launching the diabetes treatment Galvus in China.  

WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility

November 8, 2010 4:12 am | News | Comments

WuXi PharmaTech, a pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it had been awarded a Certificate of Good Laboratory Practice (GLP) compliance from the State Food and Drug Administration (SFDA), China's regulatory authority for pharmaceuticals, for its toxicology facility in Suzhou.

Simcere Pharmaceutical Group Receives SFDA Approval to Manufacture and Market Palonosetron in China

August 12, 2010 4:22 am | News | Comments

Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.

NeoStem's Suzhou Erye Pharmaceutical Subsidiary Passes Government Inspection for Two Manufacturing Lines at its New Facility

June 15, 2010 4:42 am | News | Comments

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that its Suzhou Erye pharmaceutical subsidiary ("Erye") passed the government inspection by the State Food and Drug Administration ("SFDA") in China to manufacture penicillin powder for injection and cephalosporin powder for injection at its new manufacturing facility which provides 50% greater manufacturing capacity than its existing plant.


Chinese Drug Regulation Official Fired Amid Probe

June 14, 2010 4:52 am | News | Comments

BEIJING (AP) — The deputy head of China's food and drug regulator is being investigated and has been dismissed from his post, a state news agency said Sunday, citing an anti-corruption agency.

Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)

June 1, 2010 5:15 am | News | Comments

Sinovac Biotech Ltd., a China-based vaccine manufacturer, announced today that it has received the confirmation from the China International Tendering Company that Sinovac was selected by the Beijing Centers for Diseases Control and Prevention (Beijing CDC) to supply the Company's hepatitis A vaccine, Healive, to the Beijing Expanded Program of Immunization (EPI).  

Sinovac Submits Clinical Trial Application for Mumps Vaccine to SFDA

May 5, 2010 4:47 am | News | Comments

Sinovac Biotech Ltd., a China-based vaccine manufacturer, announced today that its 30%-owned joint venture, Sinovac Dalian, has submitted an application to China's State Food and Drug Administration (SFDA) to commence human clinical trials for its mumps vaccine.

MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I

March 15, 2010 5:08 am | News | Comments

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I

China's Lotus Pharmaceuticals Reports Groundbreaking Ceremony

March 10, 2010 3:52 am | News | Comments

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), reported the groundbreaking ceremony on March 9 to construct a new building complex on the grounds of its production facility in Beijing.

Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China

February 11, 2010 11:16 am | News | Comments

Simcere Pharmaceutical Group, a pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China,

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.